Anupriya Patel launches 7th National Formulary of India 2026,

Union Minister of State for Health & Family Welfare and Chemicals & Fertilizers, Smt. Anupriya Patel, today launched the 7th Edition of the National Formulary of India (NFI), the Guidance Document for Hospitals in India for Safety Monitoring and Reporting of Medical Device-Related Adverse Events, and the ADR-PvPI 2.0 Mobile App for iOS users at the 6th National Pharmacovigilance Week programme organised by the Indian Pharmacopoeia Commission (IPC) at Dr. Ambedkar International Centre, New Delhi. The 7th Edition of the NFI has also been made available digitally through NFI Online.

The 6th National Pharmacovigilance Week, being observed from 17–23 September 2026, carries the theme “Promoting Rational Use of Medicines through Pharmacovigilance: A Step Towards Safer Healthcare.” The programme brought together senior government officials, regulators, healthcare professionals, aca

Dr. V. Kalaiselvan, Secretary-cum-Scientific Director, Indian Pharmacopoeia Commission, highlighted the role of the National Formulary of India in promoting rational use of medicines and safer prescribing practices.

Dr. Yvan J.-F. Hutin, WHO Representative to India, underscored the importance of sustained collaboration among national and international stakeholders for strengthening medicine-safety and pharmacovigilance systems.

Prof. Y. K. Gupta, President, AIIMS Kalyani; Dr. V. M. Katoch, former Director General, ICMR and Secretary, DHR; Senior officers from the Ministry of Health & Family Welfare and the Indian Pharmacopoeia Commission; and other stakeholders were also present. (UPDATED ON 21ST SEPTMBER 2026)